文献
J-GLOBAL ID:202202262308154818
整理番号:22A0410884
CD44v5ドメイン阻害はIL-4/IL-4Rシグナル伝達経路と干渉してTh2細胞の分極を抑制する【JST・京大機械翻訳】
CD44 v5 domain inhibition represses the polarization of Th2 cells by interfering with the IL-4/IL-4R signaling pathway
著者 (19件):
Yang Chun
(Department of Clinical Laboratory, The 4th Hospital of Harbin Medical University, Harbin, China)
,
Yang Chun
(Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA)
,
Yang Chun
(LeBow Institute for Myeloma Therapeutics and Jerome Lipper Center for Multiple Myeloma Research, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA, USA)
,
Lin Jianhong
(Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA)
,
Lin Jianhong
(LeBow Institute for Myeloma Therapeutics and Jerome Lipper Center for Multiple Myeloma Research, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA, USA)
,
Liang Hongyan
(Department of Clinical Laboratory, The 4th Hospital of Harbin Medical University, Harbin, China)
,
Xue Li
(Department of Clinical Laboratory, The 4th Hospital of Harbin Medical University, Harbin, China)
,
Xue Li
(Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA)
,
Xue Li
(LeBow Institute for Myeloma Therapeutics and Jerome Lipper Center for Multiple Myeloma Research, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA, USA)
,
Kwart Ariel
(Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA)
,
Kwart Ariel
(LeBow Institute for Myeloma Therapeutics and Jerome Lipper Center for Multiple Myeloma Research, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA, USA)
,
Jiang Meng
(Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA)
,
Jiang Meng
(Department of General Surgery, The 4th Hospital of Harbin Medical University, Harbin, China)
,
Zhao Jianjun
(Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA)
,
Ren Huan
(School of Medicine, Southern University of Science and Technology, Shenzhen, China)
,
Jiang Xiaofeng
(Department of Clinical Laboratory, The 4th Hospital of Harbin Medical University, Harbin, China)
,
Munshi Nikhil C
(Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA)
,
Munshi Nikhil C
(LeBow Institute for Myeloma Therapeutics and Jerome Lipper Center for Multiple Myeloma Research, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA, USA)
,
Munshi Nikhil C
(VA Boston Healthcare System, Boston, MA, USA)
資料名:
Immunology and Cell Biology
(Immunology and Cell Biology)
巻:
100
号:
1
ページ:
21-32
発行年:
2022年
JST資料番号:
W0387A
ISSN:
0818-9641
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)